923009-50-1 Usage
General Description
Tert-butyl 1-oxo-2,7-diazaspiro[4.5]decane-7-carboxylate is a chemical compound with a complex structure, containing a tert-butyl group, an oxo group, and a carboxylate group. It also features a unique spiro ring system with a diaza bridge and a decane backbone. tert-butyl 1-oxo-2,7-diazaspiro[4.5]decane-7-carboxylate is likely to have applications in organic synthesis and pharmaceutical research due to its diverse functional groups and potentially interesting biological activities. Its spiro structure and unique composition make tert-butyl 1-oxo-2,7-diazaspiro[4.5]decane-7-carboxylate of interest to chemists and researchers looking to explore new molecular architectures and potential applications in drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 923009-50-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,3,0,0 and 9 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 923009-50:
(8*9)+(7*2)+(6*3)+(5*0)+(4*0)+(3*9)+(2*5)+(1*0)=141
141 % 10 = 1
So 923009-50-1 is a valid CAS Registry Number.
InChI:InChI=1/C15H26N2O3/c1-5-16-10-8-15(12(16)18)7-6-9-17(11-15)13(19)20-14(2,3)4/h5-11H2,1-4H3
923009-50-1Relevant articles and documents
2-[BIS(4-FLUOROPHENYL)METHYL]-2,7-DIAZASPIRO[4.5]DECAN-10-ONE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF THE HUMAN DOPAMINE-ACTIVE-TRANSPORTER (DAT) PROTEIN FOR THE TREATMENT OF E.G. ATTENTION DEFICIT DISORDER (ADD)
-
Page/Page column 84, (2016/04/09)
The present invention provides compounds of formula (I) and in particular 2-[bis(4-fluorophenyl)methyl]-2,7- diazaspiro[4.5]decan-10-one derivatives and related compounds as inhibitors of human dopamine-active-transporter (DAT) protein for the treatment of sexual dysfunction, affective disorders, anxiety, depression, chronic fatigue, Tourette syndrome, Angelman syndrome, attention deficit disorder (ADD), attention deficit hyperactivity disorder (ADHD), obesity, pain, obsessive-compulsive disorder, movement disorders, CNS disorders, sleep disorders, narcolepsy, conduct disorder, substance abuse (including smoking cessation), eating disorders, and impulse control disorders.
